Clinical Trial Vanguard
Key Clinical Advances: New Epinephrine Approval and Seizure Treatment Data
Introduction Clinical research continues to deliver important therapeutic progress across emergency care and neurologic disorders. Recent updates from Clinical Trial Vanguard highlight a new FDA approval for hospital-use epinephrine and emerging long-term seizure treatment data with promising clinical responses. Below is a summary of three noteworthy developments impacting patient care and treatment paradigms. 1. FDA […]
3 mins read
